Position in EXEL
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$5,271,512
+$1,143,007 QoQ
Shares Held
96,885
+0.7% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2
of 47 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $116,572,434 across 52 Biotechnology names. EXEL ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
71,735 | $13,434,530 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
241,565 | $9,348,565 | |
| 3 | IMNM |
Immunome Inc.
|
268,167 | $5,682,458 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
76,076 | $5,666,140 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
96,885 | $5,271,512 | |
| 6 | NUVL |
Nuvalent, Inc.
|
41,187 | $5,086,594 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
135,847 | $5,063,017 | |
| 8 | CGON |
CG Oncology, Inc.
|
68,702 | $4,881,277 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,271,512 | 96,885 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $4,128,505 | 96,258 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,830,654 | 87,398 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,447,396 | 59,259 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,936,389 | 66,615 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,639,632 | 71,496 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,640,224 | 49,256 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||